Gelion plc

Gelion plc

GELN.L
Gelion plcGB flagLondon Stock Exchange
17.00
GBp
-1.00
- -
30.13MMarket Cap
Gelion plc
GELN.L
(London Stock Exchange)

Recent

price

17.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
- -
- -
0.01
Revenue per Share
- -
-0.02
-0.02
-0.02
-0.09
-0.07
-0.06
-0.04
Basic EPS, GAAP
- -
-0.02
-0.03
-0.02
-0.06
-0.1
-0.05
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.04
-0.06
-0.08
-0.17
-0.23
-0.26
-0.26
Book Value per Share
- -
0.05
0.05
0.03
0.19
0.09
0.04
0.03
Tangible Book Value per Share
- -
106
106
106
100
108
125
147
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
1
Sales/Revenue/Turnover
- -
- -
-2,259.81
-532.19
- -
- -
- -
-576.97
Operating Margin (%)
- -
- -
- -
- -
- -
- -
1
1
Depreciation Expense
- -
-2
-2
-2
-9
-7
-8
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-2,191.55
-512.25
- -
- -
- -
-656.14
Profit Margin (%)
2
5
5
3
18
8
5
3
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
3
5
5
4
20
13
12
10
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
71.67%
-16.69%
Free Cash Flow
- -
47.88%
-17.15%
Net Income, GAAP
- -
69.97%
-24.71%
Sales/Revenue/Turnover
- -
- -
159.83%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.06
2025
- -
- -
- -
- -
-0.04
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Gelion plc Gelion plc engages in the research, development, design, manufacture and sale of advanced battery systems and energy storage solutions, focusing on next-generation technologies including sulfur-based cathodes for lithium-sulfur and sodium-sulfur batteries, zinc hybrid cells and lithium-ion battery recycling processes. The company offers zinc-bromide batteries under the Endure brand; proprietary sulfur cathode active materials; integrated battery energy storage systems with cloud-based monitoring; and customized solutions for applications in industrial light towers, solar and wind farms, desalination plants, mining pumps, passenger and heavy vehicles, electric buses and trains, irrigation systems, grid management, drones, unmanned aerial vehicles, commercial e-aviation and utility-scale stationary energy storage systems. Gelion plc operates through segments in the United Kingdom and Australia, targeting commercial and industrial enterprises, grid operators, mining, agriculture and manufacturing sectors with products that provide alternatives to lithium-ion and lead-acid batteries, emphasizing lower weight, cost, increased safety, simplified manufacturing and sustainable materials. Incorporated in 2015 and headquartered in Sydney, Australia, with registered offices in London, United Kingdom, the company wholly owns subsidiaries OXLiD Ltd and Battery Minerals Ltd in Nottingham, UK, and Gelion Technologies Pty Ltd in Australia. Recent developments include a full collaboration agreement with TDK Corporation in October 2025 to develop large-format commercial pouch cell prototypes using Gelion's sulfur battery cathode active material, building on a multi-year partnership with the Max Planck Institute of Colloids and Interfaces; strategic agreements with the University of Nottingham and UKRI; the appointment of Dr. Graham Cooley as non-executive director in 2025; and the first commercial sale of integration solutions generating revenue recognition, alongside commissioning of advanced manufacturing capabilities in Sydney and the UK to advance sulfur technologies and recycling processes.